Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Therapy areas
Gastroenterology
Gastroenterology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gastroenterology
Emmaus Life Sciences Reports Positive Top-Line Preliminary Results in First Patient in Diverticulosis Pilot TrialDecreased Size of Diverticula, Indications of Healing and Normalization of...
Biospace News
-
January 29, 2020
Gastroenterology
Tesamorelin Study Results on NAFLD Published in Lancet HIV
Gastroenterology
Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome
Gastroenterology
Genkyotex Announces Completion of 24-Week Treatment Period of Its Phase 2 Trial with GKT831 in Primary Biliary Cholangitis
Gastroenterology
Direct-Acting Antivirals for Treating Hepatitis C Virus Affect Incidence of New-Onset Diabetes: Presented at CROI
Gastroenterology
DURECT Corporation to Participate in the Berenberg NASH Day
Biospace News
-
February 21, 2019
0
Gastroenterology
Lipocine Inc. Announces FDA Clearance of IND to Commence Phase 2...
Biospace News
-
February 14, 2019
0
- Advertisement -
MOST POPULAR
Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics...
January 24, 2019
Flexion Therapeutics Announces Publication of Analysis of Patients with Unilateral Knee...
April 24, 2019
Tilak Healthcare Announces Exclusive Partnership for Co-Promotion with Novartis France
May 13, 2019
With Scrutiny of Insulin Drugmakers, Is Novo Nordisk a Buy for...
December 31, 2019
Load more
HOT NEWS
Commercial
Rivaroxaban Linked to Improved Outcomes for Patients With Atrial Fibrillation, Diabetes:...
Clinical
Aruvant Receives Orphan Drug Designation for ARU-1801 for the Treatment of...
Commercial
Arrowhead Pharmaceuticals Reports Fiscal 2019 First Quarter Results
Clinical
NIH launches large TB prevention trial for people exposed to multidrug-resistant...
